Bicara Therapeutics Inc. Common Stock
BCAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,330 | -$27,388 | -$36,846 | -$20,957 |
| Dep. & Amort. | $24 | $19 | $19 | $15 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3,492 | $3,451 | $3,181 |
| Change in WC | $3,163 | -$1,928 | $5,132 | -$11,995 |
| Other Non-Cash | $3,895 | $211 | $138 | -$276 |
| Operating Cash Flow | -$29,248 | -$25,594 | -$28,106 | -$30,032 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$42 | $0 | $0 | -$40 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$236,079 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$236,121 | $0 | $0 | -$40 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $436 | $135 | $460 | -$1,052 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $77 |
| Financing Cash Flow | $436 | $135 | $460 | -$975 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$264,933 | -$25,459 | -$27,646 | -$31,047 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $436,606 | $462,065 | $489,711 | $520,758 |
| End Cash | $171,673 | $436,606 | $462,065 | $489,711 |
| Free Cash Flow | -$29,290 | -$25,594 | -$28,106 | -$30,072 |